These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34770947)

  • 1. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.
    Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Serum Albumin Labelling with a New BODIPY Dye Having a Large Stokes Shift.
    Raskolupova VI; Popova TV; Zakharova OD; Nikotina AE; Abramova TV; Silnikov VN
    Molecules; 2021 May; 26(9):. PubMed ID: 34063643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
    Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H
    J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design of Albumin Theranostic Conjugates for Gold Nanoparticles Anticancer Drugs: Where the Seed Meets the Soil?
    Popova TV; Pyshnaya IA; Zakharova OD; Akulov AE; Shevelev OB; Poletaeva J; Zavjalov EL; Silnikov VN; Ryabchikova EI; Godovikova TS
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33451058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic RGD-Functionalized
    Kawai K; Nishimura K; Okada S; Sato S; Suzuki M; Takata T; Nakamura H
    Mol Pharm; 2020 Oct; 17(10):3740-3747. PubMed ID: 32845640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
    Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
    Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT).
    Nakase I; Katayama M; Hattori Y; Ishimura M; Inaura S; Fujiwara D; Takatani-Nakase T; Fujii I; Futaki S; Kirihata M
    Chem Commun (Camb); 2019 Nov; 55(93):13955-13958. PubMed ID: 31617510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
    Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.
    Tachikawa S; Miyoshi T; Koganei H; El-Zaria ME; Viñas C; Suzuki M; Ono K; Nakamura H
    Chem Commun (Camb); 2014 Oct; 50(82):12325-8. PubMed ID: 25182569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
    Renner MW; Miura M; Easson MW; Vicente MG
    Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the New
    Raskolupova VI; Wang M; Dymova MA; Petrov GO; Shchudlo IM; Taskaev SY; Abramova TV; Godovikova TS; Silnikov VN; Popova TV
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
    Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
    Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
    Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
    Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy.
    Okada S; Nishimura K; Ainaya Q; Shiraishi K; Anufriev SA; Sivaev IB; Sakurai Y; Suzuki M; Yokoyama M; Nakamura H
    Mol Pharm; 2023 Dec; 20(12):6311-6318. PubMed ID: 37909734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodophenyl-conjugated closo-dodecaborate as a promising small boron molecule that binds to serum albumin and accumulates in tumor.
    Nishimura K; Harrison S; Kawai K; Morita T; Miura K; Okada S; Nakamura H
    Bioorg Med Chem Lett; 2022 Sep; 72():128869. PubMed ID: 35772634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of a boronated nitroimidazole for boron neutron capture therapy.
    Swenson DH; Laster BH; Metzger RL
    J Med Chem; 1996 Mar; 39(7):1540-4. PubMed ID: 8691485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of conjugates of polyhedral boron compounds with tumor-seeking molecules for neutron capture therapy.
    Bregadze V; Semioshkin A; Sivaev I
    Appl Radiat Isot; 2011 Dec; 69(12):1774-7. PubMed ID: 21531143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis and use of boronated amino acids for boron neutron capture therapy.
    Kabalka GW; Yao ML
    Anticancer Agents Med Chem; 2006 Mar; 6(2):111-25. PubMed ID: 16529535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD Peptide-Conjugated Dodecaborate with the Ga-DOTA Complex: A Preliminary Study for the Development of Theranostic Agents for Boron Neutron Capture Therapy and Its Companion Diagnostics.
    Mishiro K; Imai S; Ematsu Y; Hirose K; Fuchigami T; Munekane M; Kinuya S; Ogawa K
    J Med Chem; 2022 Dec; 65(24):16741-16753. PubMed ID: 36512639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.